Elucidation of part of the mechanism by which lecanemab slows the progression of Alzheimer’s disease – Eisai
A collaborative research group led by Professor Kenjiro Ono of the Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, and Eisai Co., Ltd., used a newly developed… read more.